---
figid: PMC8811435__10.1177_15330338211065252-fig7
figtitle: 'Prognostic Role of Cyclin D1  in Multiple Myeloma: A Systematic  Review
  and Meta-Analysis'
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC8811435
filename: 10.1177_15330338211065252-fig7.jpg
figlink: /pmc/articles/PMC8811435/figure/fig7-15330338211065252/
number: F7
caption: Mechanism diagram for interaction between bortezomib and cyclin D1 is displayed
  in the figure below. Bortezomib can regulate expression of cyclin D1 by inhibiting
  the activity of NF- κB and down-regulating expression of EIF4EmRNA to reduce expression
  of CCND1mRNA. Cyclin D1/CDK4 activity plays an important role in the induction of
  NOXA protein, thus directly enhancing the anti-tumor effect of bortezomib. Besides,
  cyclin D1 can enhance the effect of bortezomib on PERK/CHOP axis and activate unfolded
  protein response (UPR) to induce the apoptosis pathway of bortezomib through endoplasmic
  reticulum (ER) stress.
papertitle: 'The Prognostic Role of Cyclin D1  in Multiple Myeloma: A Systematic  Review
  and Meta-Analysis.'
reftext: Yuwen Jiang, et al. Technol Cancer Res Treat. 2022;21:15330338211065252.
year: '2022'
doi: 10.1177/15330338211065252
journal_title: Technology in Cancer Research & Treatment
journal_nlm_ta: Technol Cancer Res Treat
publisher_name: SAGE Publications
keywords: multiple myeloma | prognosis | bortezomib | cyclin D1 | meta-analysis
automl_pathway: 0.9445843
figid_alias: PMC8811435__F7
figtype: Figure
redirect_from: /figures/PMC8811435__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8811435__10.1177_15330338211065252-fig7.html
  '@type': Dataset
  description: Mechanism diagram for interaction between bortezomib and cyclin D1
    is displayed in the figure below. Bortezomib can regulate expression of cyclin
    D1 by inhibiting the activity of NF- κB and down-regulating expression of EIF4EmRNA
    to reduce expression of CCND1mRNA. Cyclin D1/CDK4 activity plays an important
    role in the induction of NOXA protein, thus directly enhancing the anti-tumor
    effect of bortezomib. Besides, cyclin D1 can enhance the effect of bortezomib
    on PERK/CHOP axis and activate unfolded protein response (UPR) to induce the apoptosis
    pathway of bortezomib through endoplasmic reticulum (ER) stress.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DDIT3
  - EIF2AK3
  - RENBP
  - SUGP1
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CDK4
  - PMAIP1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - AKT1
  - AKT2
  - AKT3
  - Ddit3
  - Eif2ak3
  - Lamp1
  - Nfkb1
  - Cdk4
  - Pmaip1
  - Eif4e
  - Akt1
  - PEK
  - rl
  - rb
  - Rbp
  - Rbp9
  - Tbp
  - br
  - ebi
  - E2f2
  - E2f1
  - LanB2
  - anon-70Db
  - Dif
  - dl
  - Rel
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4E1
  - eIF4EHP
  - Akt
---
